Growth monitoring to detect children with cystic fibrosis.
OBJECTIVE
Cystic fibrosis (CF) in infancy and childhood is often associated with failure to thrive (FTT). This would suggest that in countries without a newborn screening program for CF, FTT could be used as a clinical screening tool. The aim of this study is to assess the diagnostic performance of FTT for identifying children with CF.


METHODS
Longitudinal length and weight measurements up to 2.5 years of age were used from CF patients (n = 123) and a reference group (n = 2,151) in The Netherlands. Growth measurements after diagnosis were excluded. We developed five potential screening rules based upon length, weight and body mass index (BMI) standardized by age and gender (SDS). Outcome measures were sensitivity, specificity and positive predictive value (PPV).


RESULTS
BMI SDS had the highest sensitivity at low false-positive rates. An efficient scenario is a BMI SDS below -2.5 SD in combination with a decrease in BMI SDS of at least 0.5 SD. This scenario had a sensitivity of 32%, a specificity of 98.3% and a PPV of 0.75%.


CONCLUSIONS
In the absence of a newborn screening program, young children with FTT for BMI are candidates to consider testing for CF.
van Dommelen
Paula
P
Department of Statistics, TNO Quality of Life, Leiden, The Netherlands. Paula.vanDommelen@tno.nl
Grote
Floor K
FK
Oostdijk
Wilma
W
de Muinck Keizer-Schrama
Sabine M P F
SM
Bouquet
Jan
J
Hendriks
Johannes J E
JJ
Kouwenberg
Jan
J
Verkerk
Paul H
PH
van Buuren
Stef
S
Wit
Jan M
JM
D000375:Aging; D001827:Body Height; D015992:Body Mass Index; D001835:Body Weight; D002675:Child, Preschool; D016001:Confidence Intervals; D003550:Cystic Fibrosis / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology; D005183:Failure to Thrive / Q000175:diagnosis / Q000209:etiology*; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008137:Longitudinal Studies; D008297:Male; D008403:Mass Screening / Q000379:methods*; D009426:Netherlands / Q000453:epidemiology; D012017:Referral and Consultation / Q000592:standards; D012680:Sensitivity and Specificity; D012737:Sex Factors